Filing Details

Accession Number:
0001765581-20-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-10 16:40:15
Reporting Period:
2020-08-06
Accepted Time:
2020-08-10 16:40:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202769 L Paul Berns 5Th Fl, Waterloo Exchange
Waterloo Rd
Dublin 4 L2
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-08-06 2,705 $0.00 10,671 No 4 A Direct
Ordinary Shares Disposition 2020-08-07 931 $125.87 9,740 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Non-Qualified Stock Option (right to buy) Acquisiton 2020-08-06 6,765 $0.00 6,765 $127.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,765 2030-08-05 No 4 A Direct
Footnotes
  1. These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021.
  2. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  3. These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021.